Characteristic* | No. (%) of patients | ||||
---|---|---|---|---|---|
2012/13 n = 2455 | 2013/14 n = 2508 | 2014/15 n = 2509 | 2015/16 n = 2448 | 2016/17 n = 2457 | |
Age group, yr | |||||
< 1 | 1252 (51.0) | 1334 (53.2) | 1375 (54.8) | 1276 (52.1) | 1242 (50.5) |
1–4 | 340 (13.8) | 315 (12.6) | 278 (11.1) | 285 (11.6) | 294 (12.0) |
5–9 | 147 (6.0) | 155 (6.2) | 171 (6.8) | 164 (6.7) | 176 (7.2) |
10–14 | 150 (6.1) | 142 (5.7) | 135 (5.4) | 138 (5.6) | 131 (5.3) |
15–19 | 217 (8.8) | 210 (8.4) | 200 (8.0) | 221 (9.0) | 245 (10.0) |
20–25 | 349 (14.2) | 352 (14.0) | 350 (13.9) | 364 (14.9) | 369 (15.0) |
Sex | |||||
Male | 1378 (56.1) | 1423 (56.7) | 1368 (54.5) | 1364 (55.7) | 1368 (55.7) |
Female | 1077 (43.9) | 1085 (43.3) | 1141 (45.5) | 1084 (44.3) | 1089 (44.3) |
Socioeconomic status† | |||||
1 (lowest income group) | 554 (22.6) | 536 (21.4) | 527 (21.0) | 565 (23.1) | 512 (20.8) |
2 | 517 (21.1) | 514 (20.5) | 562 (22.4) | 518 (21.2) | 479 (19.5) |
3 | 474 (19.3) | 478 (19.1) | 487 (19.4) | 459 (18.8) | 492 (20.0) |
4 | 492 (20.0) | 526 (21.0) | 496 (19.8) | 524 (21.4) | 499 (20.3) |
5 (highest income group) | 389 (15.8) | 430 (17.1) | 404 (16.1) | 341 (13.9) | 432 (17.6) |
Missing or unknown | 29 (1.2) | 24 (1.0) | 33 (1.3) | 41 (1.7) | 43 (1.8) |
Taxonomic unit | |||||
Perinatal | 1003 (40.9) | 1052 (41.9) | 1121 (44.7) | 1032 (42.2) | 980 (39.9) |
Congenital | 444 (18.1) | 458 (18.3) | 436 (17.4) | 434 (17.7) | 456 (18.6) |
Oncology | 390 (15.9) | 401 (16.0) | 380 (15.1) | 393 (16.1) | 413 (16.8) |
Neurology | 134 (5.5) | 128 (5.1) | 112 (4.5) | 122 (5.0) | 125 (5.1) |
Metabolic | 32 (1.3) | 26 (1.0) | 31 (1.2) | 29 (1.2) | 30 (1.2) |
Otherwise specified | 452 (18.4) | 443 (17.7) | 429 (17.1) | 438 (17.9) | 453 (18.4) |